These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 18342814)
1. Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): when, how and for whom? Marcondes M; Deeg HJ Best Pract Res Clin Haematol; 2008 Mar; 21(1):67-77. PubMed ID: 18342814 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
4. The evolution of hematopoietic SCT in myelodysplastic syndrome. Kindwall-Keller T; Isola LM Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532 [TBL] [Abstract][Full Text] [Related]
5. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review]. Zhang Z; Li X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102 [TBL] [Abstract][Full Text] [Related]